ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Amarin defends Vascepa's CV-prevention data against supplement makers eager to cash in
May 09, 2019Amarin spent years, millions of dollars and a lot of willpower proving its fish oil-based drug Vascepa really could cut the risk of heart attacks, strokes and other cardiovascular problems. To make that effort pay off, it needs to keep that proof to itsel
Pharma Sources Insight January 2025
